|
FAM13B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.59776999999472E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.388250E-02 |
| Normal-vs-Stage2 |
3.217700E-02 |
| Normal-vs-Stage3 |
5.08660000009264E-07 |
| Normal-vs-Stage4 |
7.5350999884094E-09 |
| Stage1-vs-Stage2 |
3.936800E-01 |
| Stage1-vs-Stage3 |
5.196600E-04 |
| Stage1-vs-Stage4 |
1.79797999999565E-05 |
| Stage2-vs-Stage3 |
3.135800E-01 |
| Stage2-vs-Stage4 |
9.840100E-02 |
| Stage3-vs-Stage4 |
2.685000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.61083999999923E-05 |
| Normal-vs-AfricanAmerican |
2.048800E-04 |
| Normal-vs-Asian |
9.076200E-01 |
| Caucasian-vs-AfricanAmerican |
4.385200E-01 |
| Caucasian-vs-Asian |
1.855160E-01 |
| AfricanAmerican-vs-Asian |
9.934200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.18489999999072E-05 |
| Normal-vs-Female |
1.351870E-04 |
| Male-vs-Female |
7.511800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.789200E-04 |
| Normal-vs-Age(41-60Yrs) |
4.856600E-03 |
| Normal-vs-Age(61-80Yrs) |
7.44960000020889E-07 |
| Normal-vs-Age(81-100Yrs) |
5.763000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.189000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.367800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.091800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.608300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.621030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.513000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.678800E-01 |
| Normal-vs-Grade 2 |
4.818400E-02 |
| Normal-vs-Grade 3 |
2.95549999995703E-06 |
| Normal-vs-Grade 4 |
1.71851421981728E-12 |
| Grade 1-vs-Grade 2 |
8.257200E-01 |
| Grade 1-vs-Grade 3 |
2.026000E-01 |
| Grade 1-vs-Grade 4 |
2.412800E-04 |
| Grade 2-vs-Grade 3 |
6.182400E-03 |
| Grade 2-vs-Grade 4 |
2.07080019798411E-10 |
| Grade 3-vs-Grade 4 |
1.74396000000021E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.478380E-01 |
| Normal-vs-ccB subtype |
2.55650000002827E-06 |
| ccA subtype-vs-ccB subtype |
5.950900E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.50970000000795E-05 |
| Normal-vs-N1 |
2.594200E-02 |
| N0-vs-N1 |
3.758800E-01 |
|
|
